Mainland-traded pharma stock prices rise 10pc as a sector in 2018 so far, the best-performing industry on the CSI 300 Index. China's pharmaceutical industry is poised for major growth.
As the pharma and biotech industry rolls to the end of another quarter, some investors are keen to pick up information about possible stock surges due to positive pipelines, favorable regulatory news and the overall economic health of the country.
Biotech company valuations can be a little weird. Maybe not as weird as some tech companies that trade in information or communication and have no particular product.